Who We Are
A Coalition Built to Protect National Health Security
The Alliance for Biosecurity is a coalition of biopharmaceutical companies and laboratory/academic partners that promotes a strong public-private partnership to ensure medical countermeasures are available to protect public health and enhance national health security. The Alliance advocates for public policies and funding to support the rapid development, production, stockpiling, and distribution of critically needed medical countermeasures.
Alliance Accomplishments
Trusted resource to government
Serves as a trusted industry resource to Congress, ASPR, BARDA, and the Administration, advising on stronger public-private partnerships and PHEMCE transparency.
Sustained, bipartisan program support
Built sustained, bipartisan support for BARDA, the SNS, Project BioShield SRF, and Pandemic Influenza Preparedness, including testimony before House Labor-HHS Appropriators.
Greater PHEMCE transparency
Secured greater industry participation and transparency within PHEMCE, bringing private-sector input to procurement and stockpile requirements.
2018–2019 PAHPA reforms
Drove reforms moving SNS oversight to ASPR, establishing Pandemic Influenza Preparedness as an annual appropriations priority, and extending the MCM Priority Review Voucher Program.
Bipartisan anthrax preparedness
Endorsed H.R. 2707, the Protecting American Families and Servicemembers from Anthrax Act, strengthening HHS-DoD coordination and SNS preparedness.
Operation Warp Speed
Advised on the creation of Operation Warp Speed and documented member capabilities, helping deliver COVID-19 vaccines, therapeutics, and diagnostics at record speed.
Congressional Biodefense Caucus
Helped establish the Congressional Biodefense Caucus, a bipartisan forum educating Members of Congress on biological threats and MCM preparedness.
National Biosecurity Survey
Conducted a national survey measuring public support for federal biodefense programs, using the results to recruit new congressional champions.
Biodefense as a national priority
Elevated biodefense as a national security and industrial-base priority, championing resilient U.S. biomanufacturing and reduced reliance on foreign supply chains.
Alliance Leadership
Christopher Frech
Senior Vice President, Global Government Affairs, Emergent BioSolutions | Alliance Chairman
"Over more than a decade, the Alliance has kept our industry's public-private partnerships intact and effective. When we speak with one voice, Washington listens, and that's what keeps America's biodefense capabilities funded and ready."
Alliance Secretariat
Squire Patton Boggs
Squire Patton Boggs provides policy, advocacy, and administrative support to the Alliance for Biosecurity, coordinating its legislative and regulatory engagement in Washington.
Visit Squire Patton Boggs →
